Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 106,657 |
|
|||||
| News | - | ||||||
| Day High | 2.85 | Low High |
|||||
| Day Low | 2.52 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| LAVA Therapeutics NV | LVTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.09 | -3.28% | 2.65 | 11:23:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.75 | 2.52 | 2.85 | 2.74 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 544 | 106,657 | $ 2.67 | $ 285,113 | - | 1.131 - 6.47 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:23:04 | 10 | $ 2.65 | USD |
LAVA Therapeutics NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 69.41M | 26.29M | - | 6.77M | -41.97M | -1.60 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
LAVA Therapeutics NV News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LVTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.94 | 3.15 | 2.52 | 2.81 | 116,970 | -0.29 | -9.86% |
| 1 Month | 3.92 | 3.9298 | 2.51 | 3.07 | 233,233 | -1.27 | -32.40% |
| 3 Months | 1.72 | 6.47 | 1.59 | 3.02 | 1,178,564 | 0.93 | 54.07% |
| 6 Months | 1.49 | 6.47 | 1.131 | 2.66 | 938,209 | 1.16 | 77.85% |
| 1 Year | 1.60 | 6.47 | 1.131 | 2.61 | 636,149 | 1.05 | 65.63% |
| 3 Years | 11.91 | 16.20 | 1.131 | 3.37 | 307,631 | -9.26 | -77.75% |
| 5 Years | 11.48 | 17.20 | 1.131 | 3.55 | 304,670 | -8.83 | -76.92% |
LAVA Therapeutics NV Description
| LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells. |
